Literature DB >> 15173425

Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice.

Donghua Li1, George L Graef, John A Yee, L Yan.   

Abstract

The effect of high-selenium (Se) soy protein on pulmonary metastasis of murine B16BL6 melanoma cells was investigated in male C57BL6 mice. Isolated soy proteins (ISP) from soybeans grown with and without Se foliar application during seed development were compared. Five diets were studied, a basal AIN-93G diet or a basal diet containing 10% low-Se ISP, 5% low-Se + 5% high-Se ISP, 10% high-Se ISP, or 10% low-Se ISP supplemented with Se equivalent to that of the 10% high-Se ISP diet. The Se concentrations of the 5 diets were 0.13, 0.13, 1.9, 3.6, and 3.0 microg/g, respectively. Mice were fed the diet for 2 wk before and 2 wk after an i.v. injection of 5 x 10(4) viable cells. At necropsy, the number and size of tumors that had developed in the lungs were determined. In the control group, 13/18 mice exhibited > or = 50 tumors. The numbers of mice with > or = 50 tumors were 8/18, 7/18, 3/18, and 6/17 in the ISP-fed groups, respectively. The differences between the 10% high-Se ISP group, the Se-supplemented 10% low-Se group, and the control were significant (P < 0.05). Dietary supplementation with 10% low-Se ISP significantly decreased the mean number of tumors per group and the tumor size compared with the control. A greater reduction in these variables occurred in mice fed the 10% high-Se ISP diet. The inhibition by the Se-supplemented 10% low-Se ISP diet was similar to that by the 10% high-Se ISP diet. The whole-blood Se concentration was inversely related to the tumor number (R = -0.87, P = 0.052), tumor cross-sectional area (R = -0.91, P < 0.05), and tumor volume (R = -0.93, P < 0.05). These findings suggest that Se is responsible for the greater antimetastatic effect of the high-Se ISP. We conclude that the high-Se soy protein has a greater inhibitory effect than the low-Se soy protein on pulmonary metastasis of melanoma cells in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173425     DOI: 10.1093/jn/134.6.1536

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

1.  β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice.

Authors:  Anita R Iskandar; Chun Liu; Donald E Smith; Kang-Quan Hu; Sang-Woon Choi; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-28

Review 2.  Proposed criteria for assessing the efficacy of cancer reduction by plant foods enriched in carotenoids, glucosinolates, polyphenols and selenocompounds.

Authors:  John W Finley
Journal:  Ann Bot       Date:  2005-03-22       Impact factor: 4.357

Review 3.  Mouse behavioural analysis in systems biology.

Authors:  Peter Van Meer; Jacob Raber
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 4.  Selenoproteins and Metastasis.

Authors:  Michael P Marciel; Peter R Hoffmann
Journal:  Adv Cancer Res       Date:  2017-09-01       Impact factor: 6.242

Review 5.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

Review 6.  Selenium and lung cancer: a systematic review and meta analysis.

Authors:  Heidi Fritz; Deborah Kennedy; Dean Fergusson; Rochelle Fernandes; Kieran Cooley; Andrew Seely; Stephen Sagar; Raimond Wong; Dugald Seely
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

7.  Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.

Authors:  Cundong Fan; Wenjie Zheng; Xiaoyan Fu; Xiaoling Li; Yum-Shing Wong; Tianfeng Chen
Journal:  Oncotarget       Date:  2014-05-15

Review 8.  Selenium: a brief review and a case report of selenium responsive cardiomyopathy.

Authors:  Abdulrahman Al-Matary; Mushtaq Hussain; Jaffar Ali
Journal:  BMC Pediatr       Date:  2013-03-25       Impact factor: 2.125

Review 9.  Is selenium a potential treatment for cancer metastasis?

Authors:  Yu-Chi Chen; K Sandeep Prabhu; Andrea M Mastro
Journal:  Nutrients       Date:  2013-04-08       Impact factor: 5.717

10.  Dietary Selenium Supplementation Modulates Growth of Brain Metastatic Tumors and Changes the Expression of Adhesion Molecules in Brain Microvessels.

Authors:  Jagoda K Wrobel; Gretchen Wolff; Rijin Xiao; Ronan F Power; Michal Toborek
Journal:  Biol Trace Elem Res       Date:  2015-12-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.